BOTOX Treatment for Overactive Bladder Now at Women First
Botox approved by the FDA for Overactive Bladder
The Food and Drug Administration (FDA) has expanded the use of Botox to treat overactive bladder when patients cannot tolerate or do not respond to medication. Scientists from Loyola University Chicago Stritch School of Medicine (SSOM) and the National Institutes of Health network found that Botox injected into the bladder muscle is twice as likely to completely eliminate overactive bladder symptoms in females than medications.
Overactive bladder is a condition in which the bladder squeezes too often or squeezes without warning. Symptoms include leaking urine (urinary incontinence), feeling the sudden and urgent need to urinate, and frequent urination. Traditional treatment has been prescribing anticholinergics to weaken bladder contractions via the nervous system, which also has a variety of side effects.
At Women First, Botox is injected into the bladder muscle with a very small needle through a cystoscope. Botox relaxes the spasm of the bladder muscle, leading to fewer episodes of urine leakage. It also allows the bladder to have a larger capacity and, therefore, require less frequent trips to the bathroom. The average duration of improvement is 5 months, and Botox injections can be repeated multiple times.
Patients tolerate the procedure very well with minimal pain and no recovery necessary. Frequently covered by insurance, the procedure is conveniently performed in our Women First office. Please call 502-891-8700 to schedule a consultation with your physician for further information.